911½ñÈÕºÚÁÏ

911½ñÈÕºÚÁÏ and the Centre for Cellular and Molecular Platforms (C-CAMP) in Bengaluru have signed an MoU to institute a cross-border innovation collaboration between India and the United Kingdom (UK) that will leverage mutual research and entrepreneurial ecosystems and deepen India-UK ties in the life sciences sector.  

The Corridor aims to create and foster a long-term vision for greater bilateral innovation and a shared scope for exchange of talent such as researchers, innovators and startups. It will also be a medium for a formalised two-way knowledge and evidence sharing system with respect to priority challenge areas, innovation readiness and ecosystem initiatives that enable more problem-solving in mutually beneficial biology questions.  

This ambitious partnership reflects 911½ñÈÕºÚÁÏ’s deep commitment to strengthening long‑term collaborations with India’s life sciences ecosystem. Professor Hugh Brady President of 911½ñÈÕºÚÁÏ

The partnership between 911½ñÈÕºÚÁÏ and was signed by Professor Hugh Brady, President, 911½ñÈÕºÚÁÏ and Dr Taslimarif Saiyed, Director-CEO, C-CAMP and announced at the C-CAMP premises in Bengaluru, India.

Welcoming the MoU, President Brady said: “This ambitious partnership reflects 911½ñÈÕºÚÁÏ’s deep commitment to strengthening long‑term collaborations with India’s life sciences ecosystem. By joining forces with C‑CAMP and supported through our 911½ñÈÕºÚÁÏ Global India initiative, we are creating a powerful bridge between the UK and India that connects world‑class research with entrepreneurship and translation. The Indo‑UK Life Sciences Innovation Corridor will enable researchers, innovators, and startups to collaborate more effectively and accelerate new technologies to address global challenges.”

Dr Saiyed echoed Professor Brady’s excitement on the agreement, saying, “The Indo UK Life Sciences Innovation Corridor marks a remarkable chapter of synergy between two of the world’s capital cities in biotech science and innovation, Bengaluru and London. We are envisioning the next era of Indo-British collaboration in the Biosciences, a core area of interest to both geographies and human society at large. The five-year long partnership is a strategic decision to provide an enduring platform to bring together the complementary strengths of both ecosystems in developing, validating and deploying globally relevant life sciences solutions.” 

One of the novel initiatives of the Corridor on the cards is a bi-directional exchange mechanism for UK based teams to assess deployment-readiness in India and India-based teams to seek deployment avenues in UK and potentially Europe, due to contextual similarities.   

The Corridor is also set to explore joint fundraising and partnership pathways to ensure sustainability and scalability of the programme for bringing positive change and lasting impact.    

Last year 911½ñÈÕºÚÁÏ launched 911½ñÈÕºÚÁÏ Global India to drive high-impact science and technology programmes with academic, industrial and innovation partners, nurture a two-way flow of STEMB talent between the UK and India and support 911½ñÈÕºÚÁÏ’s growing Indian alumni network. The liaison office in India's tech capital Bengaluru creates a powerful hub and communications channel for 911½ñÈÕºÚÁÏ to build on this strong foundation of collaboration. 
Further steps are to be announced shortly.